Wyss Center Geneva Appoints Dr. Tracy Laabs as New Director
Summary
The Wyss Center for Bio and Neuroengineering in Geneva announced the appointment of Dr. Tracy Laabs as Director, effective July 1, 2026. Under outgoing director Prof. Dr. Erwin Böttinger, the Center spun off six companies in two years including ABILITY Neurotech SA and Clee Medical SA in 2025, while building programs in AI-guided neuromodulation and minimally invasive neurotechnology. The Center also launched the AI Hub in December 2025.
Why it matters
This leadership transition at a major neurotechnology research center reflects the maturation of the European neurotech ecosystem. The Wyss Center's track record of spinning off companies and building partnerships across the Geneva ecosystem demonstrates a successful model for translating neuroscience research into clinical ventures. Dr. Laabs' appointment signals continued momentum in advancing brain-computer interface and neuromodulation technologies from lab to patient.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial